Printed From BioPortfolio.com
First-ever study in the personalised treatment of rare cancers brings promising results
05:22 EDT 18 Oct 2017 | Pharmafile
The first-ever trial to treat patients for rare cancers in a personalised manner based on the characteristics of their individual disease has wrought promising results, it has emerged.
The approach employed by the study differs from the traditional methodology which is generally determined by a cancer’s origin point, size and the stage of the disease, irrespective of the individual characteristics of the particular case. This has historically led to a huge discrepancy in success rates from patient to patient.
Original Article: First-ever study in the personalised treatment of rare cancers brings promising results
